Objectives: To assess whether JC virus (JCV) DNA is frequently harbour
ed by peripheral blood leukocytes (PBL) in HIV-positive patients, befo
re the onset of progressive multifocal leukoencephalopathy (PML). Desi
gn: The polyomavirus JCV induces PML in immunocompromised persons and
particularly AIDS patients. Leukocytes may play a central part in the
onset of PML, but their precise role in JCV latency and reactivation s
till remains hypothetical. The controversial presence of JCV DNA in PB
L has been, until now, investigated only among small groups of patient
s. We therefore studied 157 HIV-positive persons and compared them wit
h 65 HIV-negative immunocompromised patients. Methods: DNA was extract
ed from PBL. The presence of!CV DNA was demonstrated by the polymerase
chain reaction (PCR) alone or combined with a molecular hybridization
assay. Results: The presence of JCV DNA was ascertained by PCR and hy
bridization in 28.9% of 135 HIV-infected persons at all stages of HIV
infection and only 16.4% of 61 HIV-negative immunocompromised patients
. No correlation could be drawn between the detection of JCV DNA and t
he clinical or biological status of the HIV-positive patients. Conclus
ions: JCV DNA is detectable in the PBL of 28.9% of HIV-infected person
s, even in the early stages of infection. JCV is more seldomly amplifi
ed in HIV-negative immunocompromised patients. Further work is in prog
ress to determine the prognostic value of the presence of JCV DNA in t
he blood of HIV-positive patients.